Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pharma

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

Imagine this: a hospital conference room, lights low, filled with decision-makers. A sales representative clicks through slides driven by Palantir Technologies’ (NASDAQ:PLTR) Foundry platform, highlighting real-time data integration and pinpoint analytics that would make Pharma RD from the past look like it’s still sending lab results by fax. Down the…

Benzinga

Thomas Massie's New Bill Would Let People Sue Pharma for COVID Vaccine Injuries

Federal liability protections currently prevent people suing COVID-19 vaccine makers, and instead require them to request compensation from a program that's covered only 39 COVID vaccine injury claims.

Reason

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Former CDC nominee goes scorched earth, blaming two Republicans and ‘big Pharma’ for failed bid

Weldon’s nomination to head the CDC was withdrawn just 12 hours before he was supposed to testify to the Senate health committee

The Independent UK

My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup

Most individuals diagnosed with a rare disease won’t live to become teenagers or adults. I knew what I had to do.

Fortune

£20m initiative to tackle ‘historically low’ numbers in dementia clinical trials

The Dementia Trials Accelerator will allow ‘tens of thousands’ to take part in trials.

The Independent UK

Doctors rarely understand how influence really works. The result: an NHS bowing to the needs of big pharma

There must be transparency over funding to medics from the pharmaceutical industry – and that’s only the start, says the GP and writer Margaret McCartney

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Sienna Miller’s £19 French skincare secret to achieving a glowing complexion

Sienna Miller has hailed this affordable retinol cream as the "French secret to great skin" and is a must-have in your beauty bag...

Woman & Home

'Pharma Bro' behind DJT crypto token, no proof Barron Trump involved

A Twitter sleuth exposed Martin Shkreli's ties to DJT, an unauthorized Trump memecoin.

Fortune

30-year-old worker dead, about eight employees injured when Pharma bus hits stationed lorry at Lankelapalem

30-yr-old worker dies, 8 injured in Anakapalli road accident. Cause suspected to be overspeeding. Unauthorised parking of lorries alleged to be cause of accidents. Family of deceased demands compensation.

The Hindu

Under $15 Bargains: 3 Pharma Stocks to Watch

The pharmaceutical industry is anticipated to remain resilient, owing to increasing healthcare expenditure. Given this backdrop, it could be wise to watch quality pharma stocks Organon & Co. (OGN), GoodRx Holdings (GDRX), and Viatris (VTRS) trading under $15 now. Read on….

StockNews.com

Fast-paced ‘Painkiller’ depicts the making, selling and often devastating effects of OxyContin

Netflix limited series recounts Purdue Pharma’s work on the addictive drug from the perspective of its leader, some sellers, an investigator and a victim.

Chicago Sun-Times

Did Fox Really Fire Tucker Carlson for Crossing the 'Red Line' of Criticizing Big Pharma, as RFK Jr. Claims?

If so, the network failed to enforce the supposed rule before and after cancelling its top-rated host.

Reason

IBD 50 Stocks To Watch: Vertex Pharmaceuticals In Buy Zone As Firm Gets On A Roll

Vertex enters into a partnership to develop novel small molecules. Shares have gained 15% this year.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Birmingham Post

Croda's sales top £2b as profits hit £500m for East Yorkshire smart science giant

Powerful operating model and consistent execution hailed as record performance revealed

Benzinga

'Pharma Bro' Martin Shkreli Is Chilling At A Halfway House After Being Released From Prison

Well-known fraudster Martin Shkreli is hanging out at a halfway house after he was released from federal prison on Wednesday. What To Know: According to several reports, citing Shkreli's lawyer, the "Pharma bro" was released from prison after serving a little more than four years of his seven-year sentence.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Palantir Technologies

247 stories

Vertex Pharmaceuticals

181 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.